These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19601736)

  • 21. [Comparison between every-day and every-3-days fluoxetine in young, moderately depressed out-patients].
    Shiber A; Reuveni H; Elhayany A; Ben-Zion IZ
    Harefuah; 1998 Dec; 135(12):596-8, 654. PubMed ID: 10911490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment approaches to major depressive disorder relapse. Part 1: dose increase.
    Schmidt ME; Fava M; Zhang S; Gonzales J; Raute NJ; Judge R
    Psychother Psychosom; 2002; 71(4):190-4. PubMed ID: 12097783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder.
    Emmanuel NP; Ware MR; Brawman-Mintzer O; Ballenger JC; Lydiard RB
    J Clin Psychiatry; 1999 May; 60(5):299-301. PubMed ID: 10362436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA; Grant EJ; Ingram CD; Gartside SE
    Biol Psychiatry; 2007 Dec; 62(11):1228-35. PubMed ID: 17651703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech dysfunction due to trazodone--fluoxetine combination in traumatic brain injury.
    Patterson DE; Braverman SE; Belandres PV
    Brain Inj; 1997 Apr; 11(4):287-91. PubMed ID: 9134203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
    Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
    Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of fluoxetine to treat dominance aggression in dogs.
    Dodman NH; Donnelly R; Shuster L; Mertens P; Rand W; Miczek K
    J Am Vet Med Assoc; 1996 Nov; 209(9):1585-7. PubMed ID: 8899022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side effects of long-term treatment with fluoxetine.
    Buchman N; Strous RD; Baruch Y
    Clin Neuropharmacol; 2002; 25(1):55-7. PubMed ID: 11852298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms.
    Frick LR; Palumbo ML; Zappia MP; Brocco MA; Cremaschi GA; Genaro AM
    Biochem Pharmacol; 2008 May; 75(9):1817-26. PubMed ID: 18342838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients.
    Greenberg BD; Benjamin J; Martin JD; Keuler D; Huang SJ; Altemus M; Murphy DL
    Psychopharmacology (Berl); 1998 Dec; 140(4):434-44. PubMed ID: 9888619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
    Dam M; Tonin P; De Boni A; Pizzolato G; Casson S; Ermani M; Freo U; Piron L; Battistin L
    Stroke; 1996 Jul; 27(7):1211-4. PubMed ID: 8685930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine.
    Sidi H; Asmidar D; Hod R; Jaafar NR; Guan NC
    Int J Psychiatry Clin Pract; 2012 Mar; 16(1):41-7. PubMed ID: 22122658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA
    Lancet; 1995 May; 345(8961):1378. PubMed ID: 7752794
    [No Abstract]   [Full Text] [Related]  

  • 34. Biological markers and psychophysiological methods as long term response predictors to fluoxetine treatment.
    Fountoulakis KN; Kaprinis S; Iacovides A; Fotiou F; Kaprinis G
    J Affect Disord; 2004 Jun; 80(2-3):291-2. PubMed ID: 15207944
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine.
    Kobayashi K; Ikeda Y; Suzuki H
    Mol Brain; 2011 Mar; 4():12. PubMed ID: 21410937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective serotonin reuptake inhibitor exposure.
    Fitzgerald KT; Bronstein AC
    Top Companion Anim Med; 2013 Feb; 28(1):13-7. PubMed ID: 23796482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.
    Zhu SP; Mao ZF; Huang J; Wang JY
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e1-5. PubMed ID: 19473340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
    Amelin AV; Skoromets AA; Korenko LA; Tumelevich BCh; Gonchar MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):20-3. PubMed ID: 10983362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
    Med Lett Drugs Ther; 2004 Mar; 46(1178):23-4. PubMed ID: 15037858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.